Summary:
During the test, it is only necessary to collect the patient's nasal and throat swabs and other secretion samples. Within 1.5 hours, 6 common respiratory viruses, including the new coronavirus, can be detected at one time, which not only helps medical staff to quickly distinguish between normal and normal people. Novel coronavirus infection can also effectively identify influenza patients and new coronary pneumonia patients, so as to achieve accurate diagnosis and subsequent accurate treatment of patients.
Industry Insights
Due to the COVID-19 pandemic, the global COVID-19 Nucleic Acid Detection Kit market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe COVID-19 Nucleic Acid Detection Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe COVID-19 Nucleic Acid Detection Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Fluorescent PCR Method accounting for % of the COVID-19 Nucleic Acid Detection Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of COVID-19 Nucleic Acid Detection Kit include PerkinElmer, Shanghai Sidi Biomedical Technology, Jiangsu Weidi Biomedical Technology, CapitalBio Corporation, Shenzhen Zijian Biotechnology, Sun Yat-Sen University Daan Gene, Shanghai Berger Medical Technology, Shanghai Zhijiang Biotechnology and Shengxiang Biotechnology, etc. In terms of revenue, the global 3 largest players have a % market share of COVID-19 Nucleic Acid Detection Kit in 2021.
This report focuses on COVID-19 Nucleic Acid Detection Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall COVID-19 Nucleic Acid Detection Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the COVID-19 Nucleic Acid Detection Kit market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Fluorescent PCR Method
Colloidal Gold Method
Magnetic Particle Chemiluminescence
Segment by Application
Hospital
Clinic
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
PerkinElmer
Shanghai Sidi Biomedical Technology
Jiangsu Weidi Biomedical Technology
CapitalBio Corporation
Shenzhen Zijian Biotechnology
Sun Yat-Sen University Daan Gene
Shanghai Berger Medical Technology
Shanghai Zhijiang Biotechnology
Shengxiang Biotechnology
Yaneng Biotechnology Shenzhen
BGI Wuhan
Guangzhou Wanfu Biotechnology
Zhuhai Livzon Reagent
Guangdong Hexin Health Technology
Innotek (Tangshan) Biotechnology
Mike Bio
Wuhan Mingde Biotechnology
Frequently Asked Questions
Which product segment grabbed the largest share in the COVID-19 Nucleic Acid Detection Kit market?
How is the competitive scenario of the COVID-19 Nucleic Acid Detection Kit market?
Which are the key factors aiding the COVID-19 Nucleic Acid Detection Kit market growth?
Which are the prominent players in the COVID-19 Nucleic Acid Detection Kit market?
Which region holds the maximum share in the COVID-19 Nucleic Acid Detection Kit market?
What will be the CAGR of the COVID-19 Nucleic Acid Detection Kit market during the forecast period?
Which application segment emerged as the leading segment in the COVID-19 Nucleic Acid Detection Kit market?
What key trends are likely to emerge in the COVID-19 Nucleic Acid Detection Kit market in the coming years?
What will be the COVID-19 Nucleic Acid Detection Kit market size by 2028?
Which company held the largest share in the COVID-19 Nucleic Acid Detection Kit market?
Summary:
Get latest Market Research Reports on COVID-19 Nucleic Acid Detection Kit. Industry analysis & Market Report on COVID-19 Nucleic Acid Detection Kit is a syndicated market report, published as Global COVID-19 Nucleic Acid Detection Kit Market Research Report 2022. It is complete Research Study and Industry Analysis of COVID-19 Nucleic Acid Detection Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.